NCT03570047View on ClinicalTrials.gov

Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation

CompletedOBSERVATIONAL
Enrollment

73,989

Participants

Timeline

Start Date

May 8, 2018

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Non-valvular Atrial Fibrillation
Trial Locations (1)

Unknown

Pfizer Japan, Tokyo

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03570047 - Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation | Biotech Hunter | Biotech Hunter